These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38129208)

  • 1. Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients.
    Faraoni D; Guindi A; Ankola AA; Resheidat A; Binsalamah Z; Teruya J; Savorgnan F; Vener DF
    J Cardiothorac Vasc Anesth; 2024 Feb; 38(2):388-393. PubMed ID: 38129208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
    Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.
    Downey L; Brown ML; Faraoni D; Zurakowski D; DiNardo JA
    Anesth Analg; 2017 May; 124(5):1431-1436. PubMed ID: 28319507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Low Dose Recombinant Factor VIIa and 4-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Cardiac Surgery.
    Caldwell L; Bhakta R; Naik N; Knowles BD; Parker J; Van Berkel Patel M
    J Pharm Pract; 2024 Oct; 37(5):1149-1156. PubMed ID: 38261533
    [No Abstract]   [Full Text] [Related]  

  • 5. A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VII for the Management of Bleeding With Cardiac Surgery.
    Katz A; Ahuja T; Arnouk S; Lewis TC; Marsh K; Papadopoulos J; Merchan C
    J Intensive Care Med; 2022 Feb; 37(2):231-239. PubMed ID: 33402016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the Use of Recombinant Activated Factor VII and Prothrombin Complex Concentrate in Heart Transplant Patients in Virginia.
    Mazzeffi M; Beller J; Strobel R; Norman A; Wisniewski A; Smith J; Fonner CE; McNeil J; Speir A; Singh R; Tang D; Quader M; Yarboro L; Teman N
    J Cardiothorac Vasc Anesth; 2024 Mar; 38(3):660-666. PubMed ID: 38220518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
    Mehringer SL; Klick Z; Bain J; McNeely EB; Subramanian S; Pass LJ; Drinkwater D; Reddy VS
    Ann Pharmacother; 2018 Jun; 52(6):533-537. PubMed ID: 29332420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children.
    Benson JW; Hraska V; Scott JP; Stuth EAE; Yan K; Zhang J; Niebler RA
    World J Pediatr Congenit Heart Surg; 2023 May; 14(3):282-288. PubMed ID: 36919404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models.
    Ghosh S; Krege W; Doerr B; Mischnik M; Pragst I; Dickneite G; Herzog E
    PLoS One; 2021; 16(10):e0258192. PubMed ID: 34614035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
    Li Y; Zhao W; Luo Q; Wu X; Ding J; Yan F
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.
    Hayes K; Fernando MC; Jordan V
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013551. PubMed ID: 36408876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
    Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
    Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
    Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
    Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics Associated With Mortality in 372 Patients Receiving Low-Dose Recombinant Factor VIIa (rFVIIa) for Cardiac Surgical Bleeding.
    Baral P; Cotter E; Gao G; He J; Wirtz K; Sharma A; Zorn Iii T; Muehlebach G; Flynn B
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2133-2140. PubMed ID: 30772178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Early, Low-Dose Factor VIIa on Subsequent Transfusions and Length of Stay in Cardiac Surgery.
    Sutherland L; Houchin A; Wang T; Wang S; Moitra V; Sharma A; Zorn T; Flynn BC
    J Cardiothorac Vasc Anesth; 2022 Jan; 36(1):147-154. PubMed ID: 34103218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
    Okonta KE; Edwin F; Falase B
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
    Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery.
    Brase J; Finger B; He J; Wirtz K; Stun L; McMillen R; Flynn B
    Ann Thorac Surg; 2016 Jul; 102(1):35-40. PubMed ID: 26874365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.